These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25951834)

  • 1. Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.
    Schmidt C; Wiedmann F; Voigt N; Zhou XB; Heijman J; Lang S; Albert V; Kallenberger S; Ruhparwar A; Szabó G; Kallenbach K; Karck M; Borggrefe M; Biliczki P; Ehrlich JR; Baczkó I; Lugenbiel P; Schweizer PA; Donner BC; Katus HA; Dobrev D; Thomas D
    Circulation; 2015 Jul; 132(2):82-92. PubMed ID: 25951834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
    Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
    Schmidt C; Wiedmann F; Zhou XB; Heijman J; Voigt N; Ratte A; Lang S; Kallenberger SM; Campana C; Weymann A; De Simone R; Szabo G; Ruhparwar A; Kallenbach K; Karck M; Ehrlich JR; Baczkó I; Borggrefe M; Ravens U; Dobrev D; Katus HA; Thomas D
    Eur Heart J; 2017 Jun; 38(22):1764-1774. PubMed ID: 28057773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine model.
    Schmidt C; Wiedmann F; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Life Sci; 2014 Mar; 97(2):107-15. PubMed ID: 24345461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.
    Schmidt C; Wiedmann F; Langer C; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Heart Rhythm; 2014 Oct; 11(10):1798-805. PubMed ID: 24952150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.
    Dobrev D; Graf E; Wettwer E; Himmel HM; Hála O; Doerfel C; Christ T; Schüler S; Ravens U
    Circulation; 2001 Nov; 104(21):2551-7. PubMed ID: 11714649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.
    Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1003-16. PubMed ID: 22790794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation.
    Harleton E; Besana A; Chandra P; Danilo P; Rosen TS; Rosen MR; Argenziano M; Robinson RB; Feinmark SJ
    Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H126-34. PubMed ID: 25437921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation.
    Balana B; Dobrev D; Wettwer E; Christ T; Knaut M; Ravens U
    J Mol Cell Cardiol; 2003 Dec; 35(12):1399-405. PubMed ID: 14654366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation.
    Voigt N; Heijman J; Trausch A; Mintert-Jancke E; Pott L; Ravens U; Dobrev D
    J Mol Cell Cardiol; 2013 Aug; 61():142-52. PubMed ID: 23531443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Schmidt C; Wiedmann F; Voigt N; Zhou XB; Heijman J; Lang S; Albert V; Kallenberger S; Ruhparwar A; Szabó G; Kallenbach K; Karck M; Borggrefe M; Biliczki P; Ehrlich JR; Baczkó I; Lugenbiel P; Schweizer PA; Donner BC; Katus HA; Dobrev D; Thomas D
    Circulation; 2016 Mar; 133(11):e440-1. PubMed ID: 26976923
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac K
    Staudacher I; Seehausen S; Illg C; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Prog Biophys Mol Biol; 2019 Jul; 144():128-138. PubMed ID: 31182191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter by Olschewski et al Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Olschewski A; Chandran N; Olschewski H
    Circulation; 2016 Mar; 133(11):e439. PubMed ID: 26976922
    [No Abstract]   [Full Text] [Related]  

  • 15. Vernakalant activates human cardiac K(2P)17.1 background K(+) channels.
    Seyler C; Schweizer PA; Zitron E; Katus HA; Thomas D
    Biochem Biophys Res Commun; 2014 Aug; 451(3):415-20. PubMed ID: 25108155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.
    Wettwer E; Hála O; Christ T; Heubach JF; Dobrev D; Knaut M; Varró A; Ravens U
    Circulation; 2004 Oct; 110(16):2299-306. PubMed ID: 15477405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREK-1 (K
    Lugenbiel P; Wenz F; Syren P; Geschwill P; Govorov K; Seyler C; Frank D; Schweizer PA; Franke J; Weis T; Bruehl C; Schmack B; Ruhparwar A; Karck M; Frey N; Katus HA; Thomas D
    Basic Res Cardiol; 2017 Jan; 112(1):8. PubMed ID: 28005193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter.
    Franz MR; Karasik PL; Li C; Moubarak J; Chavez M
    J Am Coll Cardiol; 1997 Dec; 30(7):1785-92. PubMed ID: 9385908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
    Brundel BJ; Van Gelder IC; Henning RH; Tuinenburg AE; Wietses M; Grandjean JG; Wilde AA; Van Gilst WH; Crijns HJ
    J Am Coll Cardiol; 2001 Mar; 37(3):926-32. PubMed ID: 11693772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.
    Girmatsion Z; Biliczki P; Bonauer A; Wimmer-Greinecker G; Scherer M; Moritz A; Bukowska A; Goette A; Nattel S; Hohnloser SH; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1802-9. PubMed ID: 19959133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.